Donors respond to an appeal to support advances in cancer research

Donors have raised almost £95,000 for Oxford Cancer towards improving early cancer detection, better understanding interventions and helping to develop better immunotherapies.

---

Cancer is a major global health challenge, accounting for nearly 10 million deaths worldwide in 2020. Half of the UK population will be diagnosed with the disease in their lifetime, underscoring the urgency of work being undertaken by researchers and clinicians to develop solutions and improve patient outcomes. As a world-leading institution for cancer research, Oxford is in a strong position to help alleviate the burden of cancer on individuals and families, healthcare systems and society.

The Oxford Cancer initiative comprises over 900 researchers from more than 90 countries, working together to better understand how to prevent and treat cancer. As well as connecting people working in a range of disciplines, the initiative convenes industry and government partnerships and carries out trials to test new clinical strategies.

Thanks to the generosity of over 160 donors, almost £95,000 was raised following an appeal at the end of 2022. This support will go towards improving early cancer detection, better understanding the most appropriate interventions and helping to develop better targeted, less toxic immunotherapies.

Tim Elliott, Kidani Professor of Immuno-Oncology, said: ‘Oxford is uniquely placed to develop novel solutions to cancer because of our ability to bring together world-leading researchers from across disciplines. Donors have an important role to play in boosting our capacity to conduct this crucial research for patient and societal benefit globally.’

Support Oxford Cancer